On April 23, 2026, President Trump announced a reclassification of state-licensed medical marijuana, designating it as a less-dangerous drug. This move represents a significant shift in policy that advocates have been striving for.
The reclassification is expected to ease barriers to research on medical marijuana, potentially paving the way for further studies and understanding of its benefits and applications.
Additionally, this policy change may provide tax relief related to medical marijuana, although it does not equate to full federal legalization. The implications of this decision are still unfolding.